Home - Tandem Meetings News

February 6, 2026

Mortimer M. Bortin Lecturer to share how teamwork has advanced field

Stella Davies, MBBS, PhD, MRCP, tells how collaboration has elevated bone marrow transplant outcomes in children and adults.
February 6, 2026

Experts discuss potential developments and challenges in gene therapies

Panelists, including Julie Kanter, MD, point to examples of gene editing advancements, savvy intellectual property plans and teamwork.

MORE #TANDEM26 NEWS

February 6, 2026

Plenary session tracks the leading edge of cellular therapy in solid tumors and autoimmune disease

Experts discuss the potential impact of innovative engineered immune cells and other emerging approaches.
February 6, 2026

Session panelists review current practices and future directions in allogeneic donor selection

Experts consider how the advent of post-transplant cyclophosphamide (PTCy) has driven guideline changes and opened new possibilities.
February 5, 2026

Session to look at heterogeneity of hematopoietic stem cells behind cell therapy

Chair Christopher Hourigan, DM, DPhil, FRCP, discusses the potential for better understanding the diversity of cells that make HSC transplant successful.

February 5, 2026

Joint plenary session marks successes and challenges of cell therapy landscape

Speakers highlight real-world success in increasing treatments and note possible solutions for obstacles ahead.
February 5, 2026

Experts highlight the use of iPSC for transplant and gene therapy

Speakers detail novel studies and methods to reduce the need for patient- or donor-derived cells.
February 5, 2026

Panel to explore benefits and barriers of AI in cellular therapy

Panelist Wasay Khan, MD, PhD, explains why integrating artificial intelligence comes with hurdles.

MORE #TANDEM26 NEWS

February 6, 2026

Plenary session tracks the leading edge of cellular therapy in solid tumors and autoimmune disease

Experts discuss the potential impact of innovative engineered immune cells and other emerging approaches.
February 6, 2026

Session panelists review current practices and future directions in allogeneic donor selection

Experts consider how the advent of post-transplant cyclophosphamide (PTCy) has driven guideline changes and opened new possibilities.

February 5, 2026

Session to look at heterogeneity of hematopoietic stem cells behind cell therapy

Chair Christopher Hourigan, DM, DPhil, FRCP, discusses the potential for better understanding the diversity of cells that make HSC transplant successful.
February 5, 2026

Joint plenary session marks successes and challenges of cell therapy landscape

Speakers highlight real-world success in increasing treatments and note possible solutions for obstacles ahead.

AWARD SPOTLIGHTS

AWARD SPOTLIGHTS

MEET-THE-PROFESSOR SPOTLIGHTS